Editor's Note: The diabetes guidelines discussed below are a draft version of a consensus statement to be issued in October at the annual meeting of the European Association for the Study of Diabetes in Berlin, Germany.
Hi. I am Dr Anne Peters, and today I'm going to talk about the new ADA/EASD treatment guidelines for managing patients with type 2 diabetes. First off, my "headline" is that I think these are really good guidelines. Although guiding people is difficult, these guidelines actually begin to guide us in the treatment of our patients with type 2 diabetes.
They basically start the same way that all the old guidelines did, which is with lifestyle and metformin. That is really going to be our foundational therapy for our patients with type 2 diabetes.
Then, where they really differ from the old guidelines is, what is the second therapy? The first thing you do is ask, Does the patient have known cardiovascular disease or not?
If the answer is yes, they have known cardiovascular disease, then you enter a decision box in the algorithm to consider whether the patient has an eGFR of above or below 45. The recommendation is to start a medication that reduces
COMMENTARY
'Really Good' New Guidelines for T2 Diabetes
Anne L. Peters, MD
DisclosuresJuly 16, 2018
Editor's Note: The diabetes guidelines discussed below are a draft version of a consensus statement to be issued in October at the annual meeting of the European Association for the Study of Diabetes in Berlin, Germany.
Hi. I am Dr Anne Peters, and today I'm going to talk about the new ADA/EASD treatment guidelines for managing patients with type 2 diabetes. First off, my "headline" is that I think these are really good guidelines. Although guiding people is difficult, these guidelines actually begin to guide us in the treatment of our patients with type 2 diabetes.
They basically start the same way that all the old guidelines did, which is with lifestyle and metformin. That is really going to be our foundational therapy for our patients with type 2 diabetes.
Then, where they really differ from the old guidelines is, what is the second therapy? The first thing you do is ask, Does the patient have known cardiovascular disease or not?
If the answer is yes, they have known cardiovascular disease, then you enter a decision box in the algorithm to consider whether the patient has an eGFR of above or below 45. The recommendation is to start a medication that reduces
Medscape Diabetes © 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Anne L. Peters. 'Really Good' New Guidelines for T2 Diabetes - Medscape - Jul 16, 2018.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Anne L. Peters, MD
Professor, Keck School of Medicine; Director, University of Southern California Westside Center for Diabetes, University of Southern California, Los Angeles, California
Disclosure: Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Abbott Diabetes Care; Becton Dickinson; Bigfoot Biomedical; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Lexicon Pharmaceuticals, Inc.; Livongo; Medscape; Merck & Co., Inc.; Novo Nordisk; Omada Health; sanofi-aventis; Science 37
Received research support from: Dexcom; MannKind Corporation
Serve(d) as a member of a speakers bureau for: Novo Nordisk